Shanghai Labway Clinical Laboratory Co., Ltd. (301060.SZ)

CNY 8.9

(-0.45%)

Long Term Debt Summary of Shanghai Labway Clinical Laboratory Co., Ltd.

  • Shanghai Labway Clinical Laboratory Co., Ltd.'s latest annual long term debt in 2023 was 166.83 Million CNY , up 265.73% from previous year.
  • Shanghai Labway Clinical Laboratory Co., Ltd.'s latest quarterly long term debt in 2024 Q3 was 133.69 Million CNY , down -5.31% from previous quarter.
  • Shanghai Labway Clinical Laboratory Co., Ltd. reported annual long term debt of 45.61 Million CNY in 2022, down -8.82% from previous year.
  • Shanghai Labway Clinical Laboratory Co., Ltd. reported annual long term debt of 50.03 Million CNY in 2021, down -7.74% from previous year.
  • Shanghai Labway Clinical Laboratory Co., Ltd. reported quarterly long term debt of 141.2 Million CNY for 2024 Q2, up 0.31% from previous quarter.
  • Shanghai Labway Clinical Laboratory Co., Ltd. reported quarterly long term debt of 160.97 Million CNY for 2024 Q1, down -3.43% from previous quarter.

Annual Long Term Debt Chart of Shanghai Labway Clinical Laboratory Co., Ltd. (2023 - 2013)

Historical Annual Long Term Debt of Shanghai Labway Clinical Laboratory Co., Ltd. (2023 - 2013)

Year Long Term Debt Long Term Debt Growth
2023 166.83 Million CNY 265.73%
2022 45.61 Million CNY -8.82%
2021 50.03 Million CNY -7.74%
2020 54.22 Million CNY 0.0%
2019 - CNY 0.0%
2018 - CNY 0.0%
2017 - CNY 0.0%
2016 - CNY 0.0%
2015 - CNY 0.0%
2014 - CNY 0.0%
2013 - CNY 0.0%

Peer Long Term Debt Comparison of Shanghai Labway Clinical Laboratory Co., Ltd.

Name Long Term Debt Long Term Debt Difference
Dian Diagnostics Group Co.,Ltd. 2.33 Billion CNY 92.84%
Hangzhou Tigermed Consulting Co., Ltd. 434.22 Million CNY 61.578%
Dirui Industrial Co.,Ltd. 3.66 Million CNY -4449.676%
Beijing Strong Biotechnologies, Inc. 1.13 Billion CNY 85.257%
Medicalsystem Biotechnology Co., Ltd. 23.59 Million CNY -607.057%
Maccura Biotechnology Co.Ltd 175.47 Million CNY 4.924%
Guangzhou Wondfo Biotech Co.,Ltd 580.52 Million CNY 71.261%
Guangdong Hybribio Biotech Co.,Ltd. 28.26 Million CNY -490.187%
BGI Genomics Co., Ltd. 283.42 Million CNY 41.136%
Amoy Diagnostics Co., Ltd. 44.4 Million CNY -275.759%